Brands
Iodex unveils ‘UltraGel+’ with Rishabh Pant as brand ambassador
Mumbai: Strong odours from pain relief gels and multiple applications for all-day pain relief are now a thing of the past. Iodex, a trusted pain relief brand by Haleon (erstwhile GlaxoSmithKline Consumer Healthcare), is proud to launch its new advanced product, ‘Iodex UltraGel+’ with the scientific superiority of two per cent Diclofenac emulgel.
Renowned Indian cricketer, Rishabh Pant, has been chosen as the brand ambassador for this new launch, which was announced via a brand film ‘Ab Dard Se Din Bhar Aaram’. As the star wicketkeeper works tirelessly on bouncing back and returning to the cricket pitch, Iodex UltraGel+ is the trusted pain relief partner he relies on.
Embed link: https://www.youtube.com/watch?v=FRkorpvN-94
The new Iodex UltraGel+ carries double the strength of the active ingredient, Diclofenac DEA, which helps provide all-day relief with just two applications. Its unique emulgel formulation enables greater penetration into the skin, thus providing relief from day-to-day body pains.
The launch campaign for Iodex UltraGel+ takes one through the rigorous journey Rishabh Pant is on to make his comeback. As the Indian cricketer meticulously trains to bounce back with every rep, his determination is supported by Iodex UltraGel+. The advanced new offering with double power and all-day pain relief empowers Rishabh Pant to focus on his journey with Iodex Ultragel+ as an ally along the way.
This association with Rishabh Pant not only underscores the product’s effectiveness in helping individuals pursue their dreams without the hindrance of pain but also aligns seamlessly with his dedication and spirit.
Haleon India pain and respiratory lead, area marketing India subcontinent Bineet Jain commented on this exciting collaboration, saying, “The new Iodex UltraGel+ will redefine the pain relief landscape with its strong formulation and superior penetration providing all-day pain relief with no smell. With double power, Iodex UltraGel+ is the perfect ally for cricketer Rishabh Pant’s need for all-day pain relief while he prepares for his return to the field. As a heritage brand trusted for many generations, Iodex has always helped Indians achieve their dreams by effectively managing body pains, and this new launch is a testament to this commitment.”
The new Iodex UltraGel+ is available on One mg and Blinkit across metro cities.
Brands
Sapphire Foods FY26 revenue rises to Rs 3,125 crore, posts loss
Q4 revenue at Rs 792 crore, FY26 loss at Rs 32 crore amid cost pressures.
MUMBAI: If growth is on the menu, profitability seems to have taken a brief detour. Sapphire Foods India reported a steady rise in topline for FY26, even as rising costs weighed on profitability. Revenue from operations grew to Rs 3,125 crore for the year ended March 31, 2026, up from Rs 2,882 crore in FY25. However, the company swung to a loss, reporting a net loss of Rs 32 crore for FY26, compared to a profit of Rs 17 crore in the previous year. Total income for the year stood at Rs 3,153 crore, while total expenses climbed to Rs 3,167 crore, reflecting pressure across key cost heads.
In the March quarter, revenue came in at Rs 792 crore, compared to Rs 711 crore in the same period last year. The company reported a quarterly net loss of Rs 13 crore, against a profit of Rs 2 crore a year earlier.
Cost pressures remained visible across operations. Material costs rose to Rs 995 crore for FY26, while employee expenses increased to Rs 428 crore. Other expenses, the largest component, stood at Rs 1,229 crore, underscoring the impact of store operations and expansion-related spends.
Depreciation and amortisation expenses also climbed to Rs 392 crore for the year, reflecting continued investments in store infrastructure and growth.
At the operating level, the company reported a loss before tax of Rs 37 crore for FY26, compared to a profit of Rs 23 crore in FY25. Exceptional items added Rs 24 crore to the cost burden during the year.
On the balance sheet, total assets rose to Rs 3,256 crore as of March 31, 2026, up from Rs 3,041 crore a year earlier, indicating ongoing expansion. Net worth stood at Rs 1,389 crore.
Despite profitability pressures, operating cash flow remained resilient at Rs 507 crore, highlighting underlying business strength and demand stability.
The numbers paint a familiar picture in the quick-service restaurant space, growth continues to be served hot, but margins are still finding their footing.
